MIT Develops Nanoparticle to Boost Vaccine Efficacy

New nanoparticle technology could revolutionize vaccine delivery and potency, showing promising results in early studies.

MIT researchers have developed a new type of nanoparticle, called a metal-organic framework (MOF), that can enhance the immune response in vaccines.
The MOF, specifically ZIF-8, activates the innate immune system through toll-like receptors, offering a more controlled delivery of vaccines.
In mouse studies, vaccines using ZIF-8 showed a significantly stronger immune response compared to traditional methods.
This advancement could lead to more effective subunit vaccines for diseases like COVID-19, potentially making them easier and cheaper to produce and distribute globally.
Further research is needed to evaluate the safety and scalability of ZIF-8 for human vaccines, but the findings could guide the development of similar nanoparticle-based vaccines.